KearneyHMillerDHCiccarelliO. Spinal cord MRI in multiple sclerosis: Diagnostic, prognostic and clinical value. Nat Rev Neurol2015; 11: 327–338.
2.
ArrambideGRoviraASastre-GarrigaJet al. Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler2018; 24(3): 301–312.
DekkerISombekkeMHWitteBIet al. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis. Mult Scler2018; 24(4): 481–490.
5.
BrownleeWJ. Do spinal cord lesions matter in patients with clinically isolated syndrome and early MS?Mult Scler2018; 24(4): 430–431.
6.
KincsesZTRopeleSJenkinsonMet al.Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler17(6): 681–689.
7.
KeeganBMKaufmannTGWeinshenkerBGet al. Progressive solitary sclerosis—Gradual motor impairment from a single CNS demyelinating lesion. Neurology2016; 87: 1713–1719.
8.
KeeganBMKaufmannTGWeinshenkerBGet al. Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler2018; 24: 1445–1452.
9.
KriegerSCCookKDe NinoSet al. The topographical model of multiple sclerosis: A dynamic visualization of disease course. Neurol Neuroimmunol Neuroinflamm2016; 3(5): e279.
10.
KriegerSCSumowskiJF. New insights into multiple sclerosis clinical course from the topographical model and functional reserve. Neurol Clin2018; 36(1): 13–25.
CharilAZijdenbosAPTaylorJet al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: Application to 452 patient data sets. Neuroimage2003; 19: 532–544.
13.
AltermattAGaetanoLMagonSet al. Clinical correlations of brain lesion location in multiple sclerosis: Voxel-based analysis of a large clinical trial dataset. Brain Topogr. Epub ahead of print 29 May 2018. DOI: 10.1007/s10548-018-0652-9.